(Q55463244)

12 July 2018

title

IDH1 mutation, a genetic alteration associated with adult gliomatosis cerebri. (English)

1 reference

12 July 2018

author name string

Deepti Narasimhaiah

1

1 reference

12 July 2018

Catherine Miquel

2

1 reference

12 July 2018

Elisabeth Verhamme

3

1 reference

12 July 2018

Paul Desclée

4

1 reference

12 July 2018

Guy Cosnard

5

1 reference

12 July 2018

Catherine Godfraind

6

1 reference

12 July 2018

publication date

11 April 2011

1 reference

12 July 2018

published in

Neuropathology

1 reference

12 July 2018

volume

32

1 reference

12 July 2018

issue

1

1 reference

12 July 2018

page(s)

30-37

1 reference

12 July 2018

Histological and MR correlations in Gliomatosis cerebri

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2011.01216.X

Gliomatosis cerebri presenting as intractable epilepsy during early childhood

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2011.01216.X

Gliomatosis cerebri in young patients' report of three cases and review of the literature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2011.01216.X

Gliomatosis cerebri: 20 years of experience at the Children's Hospital of Philadelphia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2011.01216.X

An integrated genomic analysis of human glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2011.01216.X

IDH1 and IDH2 mutations in gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2011.01216.X

Analysis of the IDH1 codon 132 mutation in brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2011.01216.X

Integrated molecular genetic profiling of pediatric high-grade gliomas reveals key differences with the adult disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2011.01216.X

Prognostic significance of histological grading, p53 status, YKL-40 expression, and IDH1 mutations in pediatric high-grade gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2011.01216.X

IDH1 mutations are early events in the development of astrocytomas and oligodendrogliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2011.01216.X

Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2011.01216.X

Detection of IDH1 mutations in gliomatosis cerebri, but only in tumors with additional solid component: evidence for molecular subtypes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2011.01216.X

Gliomatosis cerebri, imaging findings of 12 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2011.01216.X

Tumour necrosis and microvascular proliferation are associated with 9p deletion and CDKN2A alterations in 1p/19q-deleted oligodendrogliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2011.01216.X

Diagnostic use of IDH1/2 mutation analysis in routine clinical testing of formalin-fixed, paraffin-embedded glioma tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2011.01216.X

IDH1 mutations in gliomas: when an enzyme loses its grip

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2011.01216.X

Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2011.01216.X

Glioma-derived mutations in IDH: from mechanism to potential therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2011.01216.X

Glioma-derived mutations in IDH1 dominantly inhibit IDH1 catalytic activity and induce HIF-1alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2011.01216.X

Cancer-associated IDH1 mutations produce 2-hydroxyglutarate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2011.01216.X

Hydroxyglutaric aciduria and malignant brain tumor: a case report and literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2011.01216.X

The new WHO classification of brain tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2011.01216.X

Gliomatosis cerebri: molecular pathology and clinical course

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2011.01216.X

Genetic aberrations in gliomatosis cerebri support monoclonal tumorigenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2011.01216.X

Molecular genetic alterations in gliomatosis cerebri: what can we learn about the origin and course of the disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2011.01216.X

Gliomatosis cerebri: growing evidence for diffuse gliomas with wide invasion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2011.01216.X

Array-based comparative genomic hybridization and immunohistochemical studies in gliomatosis cerebri

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2011.01216.X

alpha-Internexin expression identifies 1p19q codeleted gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2011.01216.X

Activating mutations in BRAF characterize a spectrum of pediatric low-grade gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2011.01216.X

IDH1 and IDH2 mutations in gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2011.01216.X

IDH1 mutations are common in malignant gliomas arising in adolescents: a report from the Children's Oncology Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2011.01216.X

Gliomatosis cerebri: a review of 296 cases from the ANOCEF database and the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2011.01216.X

Combined molecular analysis of BRAF and IDH1 distinguishes pilocytic astrocytoma from diffuse astrocytoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2011.01216.X

Segregation of non-p.R132H mutations in IDH1 in distinct molecular subtypes of glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2011.01216.X

IDH1 mutations are present in the majority of common adult gliomas but rare in primary glioblastomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2011.01216.X

Molecular pathogenesis of pediatric astrocytic tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2011.01216.X

IDH1 mutations as molecular signature and predictive factor of secondary glioblastomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2011.01216.X

10.1111/J.1440-1789.2011.01216.X

21 January 2018

Identifiers

DOI

1 reference

12 July 2018

1 reference

12 July 2018